37th Annual Winter Meeting of The Toxicology Forum
VIEW FULL AGENDA HERE
or copy and paste this into your browser
Keynote Address
Janet Woodcock, FDA, MD
Keynote Address
Peter Kim, Merck Research Laboratories, PA
SESSIONS:
- Advancing Risk Assessment Approaches in the 21st Century
- Recent Successes and Future Challenges in Accelerating Implementation of the NRC Tox 21 Report
- Patient Risk Assessment Based on Carcinogenicity Evaluation of Pharmaceuticals
- Irradiation in the Production, Processing and Handling of Food: The U.S. Framework
- Threshold of Toxicological Concern: Designs, Domains, and Databases
- Improving our Understanding of the Cancer Risk Posed by Hexavalent Chromium in Drinking Water
- When Epidemiology and Toxicology Collide: Navigating the Path Forward for Formaldehyde
- Use of New Data on the Former Fuel Additive, MTBE, in Hazard Identification and Risk Assessment
UPDATES:
- NTP Workshop: Role of Environmental Chemicals in the Development of Diabetes and Obesity
- FDA’s Guidance for Industry on Reproductive and Developmental Toxicities
- The ELSIE Database: Extractable, Leachable and Knowledge Sharing Amongst Pharmaceutical Companies and Regulators
- FDA’s Dietary Supplements Office: New Director/New Directions
- FDA’s Medical Countermeasures (MCM) Initiative: Responding Faster and More Effectively toBioterrorism and Infectious Diseases
- A Therapeutic Intervention that Mitigates Intestinal Acute Radiation Poisoning
- Protecting the U.S. Food Supply from Foods Contaminated with Radionuclides From a Nuclear Reactor Accident?
